Pfizer Inc. news

   Watch this stock
Showing stories 1 - 10 of about 183   

Articles published

PFE 27.80 -0.03 (-0.11%)
price chart
Can This 1 Breast Cancer Drug Turn Pfizer Inc. Into a Growth Stock?
Big Pharma is undergoing a radical face-lift due to the avalanche of top-selling drugs losing patent protection. The consequences of the aptly named "patent cliff" have been widespread and immense in scope.
Pfizer Inc. (PFE): Why You Should Sell the Stock [AstraZeneca plc (ADR)]
buyers and sellers Lawrence Meyers: Pfizer Inc. (NYSE:PFE) is the country's largest prescription drug maker, has strong free cash flow, lots of cash, the third-highest dividend yield among the 30 Dow stocks, is attractively valued compared to its peer ...
Multiple Contraction Can Hit Pfizer (PFE)  Seeking Alpha (registration)
Related articles »  
Should Pfizer Inc. Buy Actavis plc?
Earlier this year, a media circus erupted over Pfizer's reported interest in AstraZeneca (NYSE: AZN ) . The deal would have exceeded $100 billion and created a company roughly the same size as Johnson & Johnson. AstraZeneca brass, however, felt the ...
Pfizer Inc. Is Kicking The Tires At Actavis PLC  Benzinga
Pfizer Said to Have Approached Actavis About Possible Deal  Bloomberg
Related articles »  
Should Pfizer Inc. Buy This Surprisingly Competitive Biotech Stock?
PCSK9 inhibitors, and their potential sales, have garnered a lot of interest from investors Pfizer's (NYSE: PFE ) Lipitor peaked at well over $10 billion in annual sales.
The Most Important Number You Need to Know Before Buying Pfizer Inc. Stock
Every company has one number that defines its success more than any other. For Pfizer (NYSE: PFE ) , the world's largest pharmaceutical company, that number is... $10.7 billion. Pfizer has four blockbuster drugs coming off-patent in the United States ...
What Happens If Pfizer Inc. Doesn't Come Back For AstraZeneca plc?
Unfortunately, these figures imply that if Pfizer does not come back for Astra, Astra's shares will fall. If the company's valuation were to fall to a level similar to the rest of the sector, the shares would only be worth 3,523p. With earnings ...
AstraZeneca share price: Analysts see drugmaker as viable takeover target  iNVEZZ
Related articles »  
FDA Decides Black Box Warning Should Stay On Pfizer's Anti-Smoking Drug
An advisory panel to the US Food and Drug Administration (FDA) voted yesterday to keep the black box warning of neuropsychiatric risk on Pfizer Inc.'s (PFE) smoking-cessation drug Chantix. The advisory committee reached this conclusion after 11 out of ...
FDA scientists skeptical of Pfizer request to drop Chantix suicide warning  CTV News
FDA panel says boxed warning about suicide risk should stay on Pfizer anti ...  Minneapolis Star Tribune
Related articles »  
Former Pfizer campus nearly refilled as UM research hub
When news came out that the 174-acre Pfizer Inc. complex in Ann Arbor, a crown jewel of commercial medical research, would be shuttered as part of the drug company's cutbacks in 2007, there was a collective "what now?
One Put, One Call Option To Know About for Pfizer
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Pfizer Pfizer Inc (NYSE: PFE). So this week we highlight one interesting put contract, and one interesting call contract, from the ...
Related articles »  
FDA panel votes to keep severe warning on Pfizer anti-smoking drug
Pfizer Inc failed to convince the U.S. Food and Drug Administration to remove a black box warning on its controversial quit-smoking drug Chantix, with an advisory panel to the agency voting against the removal on Thursday.
Related articles »